Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology · 2025
The Shoulder-Tapping Sign: A Highly Specific Indicator of Neurocognitive Disorders.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Tyson Brad T, Erdodi Laszlo A, Holcomb Matthew, Roth Robert M, Agarwal Pinky
Аннотация
BACKGROUND: Perseveration, an inappropriate continuation of a response, is a well-established clinical sign of neurological dysfunction. The shoulder-tapping sign (STS) is a newly described and easily identified motor perseveration.
OBJECTIVE: Investigate the diagnostic utility of the STS for identifying neurocognitive disorders in patients referred for neuropsychological evaluation.
METHOD: We administered a five-step verbal command from the Commands subtest of the Boston Diagnostic Aphasia Examination ("Tap each shoulder twice with two fingers keeping your eyes shut") to 400 consecutive patients ( MAGE = 67.3, SD = 10.9) with suspected cognitive decline. The STS sign was considered positive if the patient tapped either shoulder more than twice. The STS was analyzed as a measure of neurocognitive disorder and compared with the final diagnosis. Analysis included calculations of sensitivity, specificity, and positive and negative likelihood ratios with 95% confidence intervals.
RESULTS: The STS was positive in 23% of our sample, 96% of whom met criteria for a neurocognitive disorder. The STS was seen in 38% with dementia, 21% with mild neurocognitive disorder, and 4% with no neurocognitive diagnosis. As a diagnostic marker of neurocognitive disorders, the STS had a specificity of 0.96 and sensitivity of 0.28. Positive and negative likelihood ratios were 6.15 and 0.76, respectively.
CONCLUSIONS: The STS is a highly specific indicator of neurocognitive disorders. Despite low sensitivity, the brevity and potential diagnostic yield make it a valuable addition to the cognitive assessment toolkit. When positive, the STS can be a defining feature of neurocognitive disorders in brief mental status examinations.
OBJECTIVE: Investigate the diagnostic utility of the STS for identifying neurocognitive disorders in patients referred for neuropsychological evaluation.
METHOD: We administered a five-step verbal command from the Commands subtest of the Boston Diagnostic Aphasia Examination ("Tap each shoulder twice with two fingers keeping your eyes shut") to 400 consecutive patients ( MAGE = 67.3, SD = 10.9) with suspected cognitive decline. The STS sign was considered positive if the patient tapped either shoulder more than twice. The STS was analyzed as a measure of neurocognitive disorder and compared with the final diagnosis. Analysis included calculations of sensitivity, specificity, and positive and negative likelihood ratios with 95% confidence intervals.
RESULTS: The STS was positive in 23% of our sample, 96% of whom met criteria for a neurocognitive disorder. The STS was seen in 38% with dementia, 21% with mild neurocognitive disorder, and 4% with no neurocognitive diagnosis. As a diagnostic marker of neurocognitive disorders, the STS had a specificity of 0.96 and sensitivity of 0.28. Positive and negative likelihood ratios were 6.15 and 0.76, respectively.
CONCLUSIONS: The STS is a highly specific indicator of neurocognitive disorders. Despite low sensitivity, the brevity and potential diagnostic yield make it a valuable addition to the cognitive assessment toolkit. When positive, the STS can be a defining feature of neurocognitive disorders in brief mental status examinations.